Inhalable Drugs Market Size to Record US$ 40.10 Bn through 2028

The global Inhalable Drugs market size is expected to be worth around US$ 40.10 billion by 2028, according to a new report by Vision Research Reports.

The global Inhalable Drugs market size was valued at US$ 25.05 billion in 2020 and is anticipated to grow at a CAGR of 6.8% during forecast period 2021 to 2028.

Get Sample Copy of This Report@ https://www.visionresearchrepo...

Growth Factors

Rising prevalence of respiratory diseases and increasing geriatric population are some of the key factors expected to drive the market. Chronic obstructive pulmonary disease (COPD) is a life-threatening respiratory ailments, which is projected to become the third leading cause of death globally. This will increase the demand for inhalable drugs.

According to the Global Burden of Disease study, in 2016, 251 million cases of COPD were reported worldwide. Hence, the need for developing new inhalable drugs has increased. For instance, in January 2019, Verona Pharma received WHO approval for developing Ensifentrine indicated for COPD, which has completed Phase II of clinical trials.

Advancements in inhalable drugs is anticipated to propel the inhalable drugsmarket. Nanoparticles are studied for the development of advanced inhalation drugs. For instance, in April 2019, a scientist from Queensland University of Technology conducted a research using chitosan nanoparticles loaded with inhalation powder for lung cancer. These nanoparticles can easily penetrate the lower respiratory tract and can diffuse into the bloodstream.

Rising prevalence of non-respiratory diseases such as diabetes and Parkinson’s diseases is also expected to drive the market. Therefore, manufacturers are developing cost-effective and innovative inhalable drugs. For instance, in January 2019, MannKind Corporation developed and commercialized Afrezza for diabetic patients.

Report Highlights

The market has been segmented on the basis of product into aerosols, dry powder formulation, and spray. Dry powder formulation dominated the inhalable drugs market in 2020 owing to higher efficacy and better results in comparison with other forms. Furthermore, the presence of a wide range of products and a strong pipeline for this formulation are factors responsible for its dominant market share.

The focus of manufacturers on developing small-sized particle products has increased, which is expected to fuel the market growth during the forecast period. For instance, in April 2019, Cipla launched Niveoli-the first extra-fine particle inhaler developed in India. The inhaler comprises beclomethasone-formoterol and hydrofluoroalkane (HFA), which ensures targeted delivery to small airways in asthma and COPD patients.

Inhalable drugs are widely used for the treatment of chronic respiratory diseases such as asthma, COPD, bronchospasm, as well as non-respiratory diseases such as diabetes and Parkinson’s disease. Combination therapy of Inhaled Corticosteroid (ICS), Long-Acting Muscarinic Antagonist (LAMA), and Long-Acting β2 Adrenoceptor Agonist (LABA) are extensively used for the treatment of COPDs and asthma due to its effectiveness, ability to reduce inflammation of lungs, and less need for hospitalization.

Due to the rising prevalence of diabetes and the high cost of medications, manufacturers have come up with an inhaler as an alternative therapy with reduced cost. For instance, in January 2019, MannKind Corporation developed and commercialized Afrezza for patients with diabetes. The company started a direct purchase program for inhalable insulin Afrezza for as little as USD 4 per day.

Geographically, the global market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America dominated the overall market in terms of revenue in 2018, followed by Europe. Both the markets for inhalable drugs are fueled by various awareness programs conducted by governments, organizations, and companies to improve treatment options for COPD. For instance, in November 2016, Mylan organized the COPD Awareness Month to raise awareness about various treatments (inhaled and other bronchodilators) and their different dosage forms.

The Asia Pacific market for inhalable drugs is anticipated to be the fastest-growing segment over the forecast period. This can be attributed to factors such as improving healthcare infrastructure, rising patient awareness, and increasing disposable income. Moreover, new market entrants lead to strong competition, which is expected to play an important role in providing a growth platform to this regional market over the next few years. Growing medical tourism in several Asian countries is also attracting the attention of leading global players to set up in numerous emerging economies with significant growth potential.

Key Players

AstraZeneca; Sanofi; Vectura; Mylan; GlaxoSmithKline; Mundipharma; Boehringer Ingelheim International GmbH; and Cipla Inc.

Market Segmentation

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Scope and Assumptions
1.3 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
Chapter 4 Market Definitions
Chapter 5 Industry Outlook
5.1 Market Driver Analysis
5.1.1 Rising prevalence of respiratory and non-respiratory diseases
5.1.2 Rising geriatric population
5.1.3 advancements IN therapies
5.2 Market Restraint Analysis
5.2.1 Stringent regulations
5.2.2 Availability of alternative therapy
5.3 Key Opportunities Prioritized
Chapter 6 Business Environment Analysis
6.1 SWOT analysis; by factor (Political & legal, economic, and technological)
6.2 Porter’s five forces analysis
6.3 Major Deals & Strategic Alliances
6.3.1 Joint Ventures
6.3.2 Mergers and Acquisition
6.3.3 Licensing and Partnership
6.3.4 Technological Collaborations
6.3.5 Strategic Divestment
6.3.6 Market Entry Strategies
6.4 Respiratory Diseases Prevalence
6.4.1 Asthma
6.4.2 Chronic Obstructive Pulmonary Disease
6.4.3 Pulmonary Fibrosis
6.4.4 Cystic Fibrosis
6.4.5 Allergic Rhinitis (Hay fever)
6.5 Top Inhalable Drugs
6.6 Pipeline Drugs
Chapter 7 Inhalable Drugs Market: Product Estimates & Trend Analysis
7.1 Inhalable Drugs Market: Product Movement Analysis
7.1.1 Aerosol
7.1.1.1 Aerosol inhalable drugs market, 2017 - 2028 (USD Million)
7.1.2 Dry powder formulation
7.1.2.1 Dry powder formulation inhalable drugs market, 2017 - 2028 (USD Million)
7.1.3 Spray
7.1.3.1 Spray inhalable drugs market, 2017 - 2028 (USD Million)
Chapter 8 Inhalable Drugs Market: Application Estimates & Trend Analysis
8.1 Inhalable Drugs Market: Application Movement Analysis
8.1.1 Respiratory diseases
8.1.1.1 Respiratory diseases inhalable drugs market, 2017 - 2028 (USD Million)
8.1.2 Non-respiratory diseases
8.1.2.1 Non-Respiratory diseases inhalable drugs market, 2017 - 2028 (USD Million)
Chapter 9 Inhalable Drugs Market: Regional Estimates & Trend Analysis, by Product, Application
9.1 Inhalable Drugs Market: Regional Movement Analysis
9.2 North America
9.2.1 North America inhalable drugs market estimates and forecasts, 2017 - 2028 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S. inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.2.3 Canada
9.2.3.1 Canada inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.3 Europe
9.3.1 Europe inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.3.2 Germany
9.3.2.1 Germany inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.3.3 U.K.
9.3.3.1 U.K. inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.3.4 France
9.3.4.1 France inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.3.5 Italy
9.3.5.1 Italy inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.3.6 Spain
9.3.6.1 Spain inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.4.2 Japan
9.4.2.1 Japan inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.4.3 China
9.4.3.1 China inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.4.4 India
9.4.4.1 India inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.4.5 South Korea
9.4.5.1 South Korea inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.5 Latin America
9.5.1 Latin America inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.5.3 Mexico
9.5.3.1 Mexico inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.5.4 Argentina
9.5.4.1 Argentina inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.6 Middle East & Africa
9.6.1 MEA inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.6.3 Saudi arabia
9.6.3.1 Saudi Arabia inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
9.6.4 UAE
9.6.4.1 UAE inhalable drugs market estimate and forecasts, 2017 - 2028 (USD Million)
Chapter 10 Company Profile
10.1 Strategy Framework
10.2 Company Profiles
10.2.1 GlaxoSmithKline plc
10.2.1.1 Company overview
10.2.1.2 Financial performance
10.2.1.3 Product benchmarking
10.2.1.4 Strategic initiatives
10.2.2 AstraZeneca
10.2.2.1 Company overview
10.2.2.2 Financial performance
10.2.2.3 Product benchmarking
10.2.2.4 Strategic initiatives
10.2.3 Boehringer Ingelheim International GmbH
10.2.3.1 Company overview
10.2.3.2 Financial performance
10.2.3.3 Product benchmarking
10.2.3.4 Strategic initiatives
10.2.4 Vectura Group plc
10.2.4.1 Company overview
10.2.4.2 Financial performance
10.2.4.3 Product benchmarking
10.2.4.4 Strategic initiatives
10.2.5 Pfizer Inc.
10.2.5.1 Company overview
10.2.5.2 Financial performance
10.2.5.3 Product benchmarking
10.2.6 Merck & Co., Inc.
10.2.6.1 Company overview
10.2.6.2 Financial performance
10.2.6.3 Product benchmarking
10.2.7 Mylan N.V.
10.2.7.1 Company overview
10.2.7.2 Financial performance
10.2.7.3 Product benchmarking
10.2.7.4 Strategic initiatives
10.2.8 Teva Pharmaceutical Industries Ltd.
10.2.8.1 Company overview
10.2.8.2 Financial performance
10.2.8.3 Product benchmarking
10.2.8.4 Strategic initiatives
10.2.9 Sunovion Pharmaceuticals Inc. (SUMITOMO DAINIPPON PHARMA)
10.2.9.1 Company overview
10.2.9.2 Financial performance
10.2.9.3 Product benchmarking
10.2.9.4 Strategic initiatives
10.2.10 Novartis AG
10.2.10.1 Company overview
10.2.10.2 Financial performance
10.2.10.3 Product benchmarking
10.2.10.4 Strategic initiatives
10.2.11 Cipla Inc.
10.2.11.1 Company overview
10.2.11.2 Financial performance
10.2.11.3 Product benchmarking
10.2.11.4 Strategic initiatives

The Inhalable Drugs market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Inhalable Drugs market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Inhalable Drugs market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Inhalable Drugs market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Inhalable Drugs market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Inhalable Drugs capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Inhalable Drugs by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Inhalable Drugs market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2028. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Inhalable Drugs market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Inhalable Drugs market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Inhalable Drugs industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

The Inhalable Drugs market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Inhalable Drugs market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Inhalable Drugs market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Inhalable Drugs market. These factors have benefited the growth of the global market for Inhalable Drugs. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Inhalable Drugs. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Inhalable Drugs are as follows:

• Historic Year: 2017-2020
• Base Year: 2020
• Forecast Year 2021 to 2028

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

• To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2028);
• Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
• Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

Buy This Premium Research Report@ https://www.visionresearchrepo...